Regulation of CTLA-4 and PD-L1 Expression in Relapsing-Remitting Multiple Sclerosis Patients after Treatment with Fingolimod, IFNβ-1α, Glatiramer Acetate, and Dimethyl Fumarate Drugs

Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS) that is characterized by inflammation which typically results in significant impairment in most patients. Immune checkpoints act as co-stimulatory and co-inhibitory molecules and play a fundamental role in...

Descripción completa

Detalles Bibliográficos
Autores principales: Derakhshani, Afshin, Asadzadeh, Zahra, Safarpour, Hossein, Leone, Patrizia, Shadbad, Mahdi Abdoli, Heydari, Ali, Baradaran, Behzad, Racanelli, Vito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400811/
https://www.ncbi.nlm.nih.gov/pubmed/34442365
http://dx.doi.org/10.3390/jpm11080721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400811/
https://www.ncbi.nlm.nih.gov/pubmed/34442365
http://dx.doi.org/10.3390/jpm11080721

Ejemplares similares